 battle war editorial rheumatoid arthritis Major advances therapy RA future scientific breakthroughs understanding pathophysiology clinical investigations hold entire focus research shifts laboratory bench Clinical studies early RA early treatment interventions major importance characterization early clinical course identification pathologic markers progressive disease formal treatment studies early disease entire role aggressive management combination chemotherapy stage RA desperate need answers clinical practice combination chemotherapy last resort treatment resistant patients conventional therapies published clinical studies valuable potential role combination chemotherapy setting studies risk drug toxicities limitations apparent combinations successes patients difficult possibility fundamental role combination chemotherapy treatment disease questions controlled trials urgent need trials combination chemotherapy gains foothold therapy